{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:36:22Z","timestamp":1759332982066},"reference-count":51,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.0668","type":"journal-article","created":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T22:17:49Z","timestamp":1438381069000},"page":"1849-1857","source":"Crossref","is-referenced-by-count":9,"title":["Serum Adiponectin Levels and Changes in Glucose Metabolism before and after Treatment for Thyroid Dysfunction"],"prefix":"10.2169","volume":"54","author":[{"given":"Didem","family":"Ozdemir","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hacettepe University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selcuk","family":"Dagdelen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hacettepe University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aydan","family":"Usman","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hacettepe University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792, 2006.","DOI":"10.1172\/JCI29126"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Snijder MB, Heine RJ, Seidell JC, et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women. Diabetes Care 29: 2498-2503, 2006.","DOI":"10.2337\/dc06-0952"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Altinova AE, Toruner F, Bukan N, Yasar DG, Akturk M, Cakir N. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J 54: 221-226, 2007.","DOI":"10.1507\/endocrj.K06-021"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Daimon M, Oizumi T, Saitoh H, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 26: 2015-2020, 2003.","DOI":"10.2337\/diacare.26.7.2015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52: 239-243, 2003.","DOI":"10.2337\/diabetes.52.2.239"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Spranger J, Kroke A, Möhlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361: 226-228, 2003.","DOI":"10.1016\/S0140-6736(03)12255-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87: 2764-2769, 2002.","DOI":"10.1210\/jcem.87.6.8550"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16: 72-75, 2003.","DOI":"10.1016\/S0895-7061(02)03197-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. J Clin Endocrinol Metab 93: 2413-2415, 2008.","DOI":"10.1210\/jc.2007-2832"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gonzalo M, Grant C, Moreno I, et al. Glucose tolerance, insulin secretion, insulin sensitivity and glucose effectiveness in normal and overweight hyperthyroid women. Clin Endocrinol 45: 689-697, 1996.","DOI":"10.1046\/j.1365-2265.1996.8500860.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ohguni S, Notsu K, Kato Y. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease. Intern Med 34: 339-413, 1995.","DOI":"10.2169\/internalmedicine.34.339"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Al Sayed A, Al Ali N, Bo Abbas Y, Alfadhli E. Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women. Endocr J 53: 653-657, 2006.","DOI":"10.1507\/endocrj.K06-018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Stanická S, Vondra K, Pelikánová T, Vleck P, Hill M, Zamravil V. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy. Clin Chem Lab Med 43: 715-720, 2005.","DOI":"10.1515\/CCLM.2005.121"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bell A, Gagnon A, Grunder L, Parikh SJ, Smith TJ, Sorisky A. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol 279: C335-C340, 2000.","DOI":"10.1152\/ajpcell.2000.279.2.C335"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nannipieri M, Cecchetti F, Anselmino M, et al. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and\/or type 2 diabetes: effects of weight loss. Int J Obes 33: 1001-1006, 2009.","DOI":"10.1038\/ijo.2009.140"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290: 1084-1089, 2002.","DOI":"10.1006\/bbrc.2001.6307"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cabanelas A, Cordeiro A, Santos Almeida NA, et al. Effect of Triiodothyronine on Adiponectin Expression and Leptin Release by White Adipose Tissue of Normal Rats. Horm Metab Res 42: 254-260, 2010.","DOI":"10.1055\/s-0029-1246118"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Saito T, Kawano T, Saito T, et al. Elevation of serum adiponectin levels in Basedow disease. Metabolism 54: 1461-1466, 2005.","DOI":"10.1016\/j.metabol.2005.05.011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yaturu S, Prado S, Grimes SR. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem 93: 491-496, 2004.","DOI":"10.1002\/jcb.20188"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Altinova AE, Törüner FB, Aktürk M, et al. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clin Endocrinol 65: 530-535, 2006.","DOI":"10.1111\/j.1365-2265.2006.02628.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yu H, Yang Y, Zhang M, et al. Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab 3: 13, 2006.","DOI":"10.1186\/1743-7075-3-13"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Santini F, Marsili A, Mammoli C, et al. Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. J Endocrinol Invest 27: RC5-RC7, 2004.","DOI":"10.1007\/BF03346252"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Aragão CN, Souza LL, Cabanelas A, Oliveira KJ, Pazos-Moura CC. Effect of experimental hypo- and hyperthyroidism on serum adiponectin. Metabolism 56: 6-11, 2007.","DOI":"10.1016\/j.metabol.2006.08.015"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Iglesias P, Alvarez Fidalgo P, Codoceo R, Díez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol 59: 621-629, 2003.","DOI":"10.1046\/j.1365-2265.2003.01897.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Baskin HJ, Cobin RH, Duick DS, et al; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8: 457-469, 2002.","DOI":"10.4158\/1934-2403-8.6.457"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.","DOI":"10.1007\/BF00280883"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Gharib H, Papini E, Valcavi R, et al; AACE\/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12: 63-102, 2006.","DOI":"10.4158\/EP.12.1.63"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Jap TS, Ho LT, Won JG. Insulin secretion and sensitivity in hyperthyroidism. Horm Metab Res 21: 261-266, 1989.","DOI":"10.1055\/s-2007-1009208"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Cettour-Rose P, Theander-Carrillo C, Asensio C, et al. Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia 48: 624-633, 2005.","DOI":"10.1007\/s00125-005-1696-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Owecki M, Nikisch E, Sowinski J. Hypothyroidism has no impact on insulin sensitivity assessed with HOMA-IR in totally thyroidectomized patients. Acta Clin Belg 61: 69-73, 2006.","DOI":"10.1179\/acb.2006.013"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Jörns A, Tiedge M, Lenzen S. Thyroxine induces pancreatic beta cell apoptosis in rats. Diabetologia 45: 851-855, 2002.","DOI":"10.1007\/s00125-002-0842-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ikeda T, Fujiyama K, Hoshino T, Takeuchi T, Tominaga M, Mashiba H. Glucose tolerance and gastric emptying in thyrotoxic rats. Metabolism 38: 874-877, 1989.","DOI":"10.1016\/0026-0495(89)90234-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Debiec H, Cross HS, Peterlik M. D-glucose uptake is increased in jejunal brush-border membrane vesicles from hyperthyroid chicks. Acta Endocrinol (Copenh) 120: 435-441, 1989.","DOI":"10.1530\/acta.0.1200435"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Fukuchi M, Shimabukuro M, Shimajiri Y, et al. Evidence for a deficient pancreatic beta-cell response in a rat model of hyperthyroidism. Life Sci 71: 1059-1070, 2002.","DOI":"10.1016\/S0024-3205(02)01791-5"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Al-Shoumer KA, Vasanthy BA, Al-Zaid MM. Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover. Endocr Pract 12: 121-130, 2006.","DOI":"10.4158\/EP.12.2.121"},{"key":"36","unstructured":"36. Tene C, Zárate A, Basurto L, et al. Correction of insulin resistance in methimazole-treated patients with Graves disease. Rev Invest Clin 53: 531-535, 2001."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Yamada T, Shirota T, Aizawa T, Takasu N. Blood glucose, serum thyroid hormones, insulin, C-peptide and C-peptide\/insulin ratio in hyperthyroid patients. Horm Metab Res 23: 504-505, 1991.","DOI":"10.1055\/s-2007-1003739"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J Mol Endocrinol 46: 155-163, 2011.","DOI":"10.1530\/JME-11-0006"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Seifi S, Nazifi S, Tabandeh MR, Saeb M. AdipoR1 and AdipoR2 gene expression are regulated by thyroid hormones in adipose tissue. Mol Cell Biochem 377: 55-63, 2013.","DOI":"10.1007\/s11010-013-1570-5"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Seifi S, Tabandeh MR, Nazifi S, Saeb M, Shirian S, Sarkoohi P. Regulation of adiponectin gene expression in adipose tissue by thyroid hormones. J Physiol Biochem 68: 193-203, 2012.","DOI":"10.1007\/s13105-011-0131-1"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Riis AL, Gravholt CH, Djurhuus CB, et al. Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 87: 4747-4753, 2002.","DOI":"10.1210\/jc.2002-020174"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Germack R, Starzec A, Perret GY. Regulation of beta 1- and beta 3-adrenergic agonist-stimulated lipolytic response in hyperthyroid and hypothyroid rat white adipocytes. Br J Pharmacol 129: 448-456, 2000.","DOI":"10.1038\/sj.bjp.0703008"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Hsieh CJ, Wang PW. Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function. Endocr J 55: 489-494, 2008.","DOI":"10.1507\/endocrj.K07E-075"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Chu CH, Lam HC, Lee JK, et al. Hyperthyroidism-associated insulin resistance is not mediated by adiponectin levels. J Thyroid Res 2011: 194721, 2011.","DOI":"10.4061\/2011\/194721"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Komatsu M, Ohfusa H, Aizawa T, Hashizume K. Adiponectin inversely correlates with high sensitive C-reactive protein and triglycerides, but not with insulin sensitivity, in apparently healthy Japanese men. Endocr J 54: 553-558, 2007.","DOI":"10.1507\/endocrj.K07-032"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Hung YJ, Chu NF, Wang SC, et al. Correlation of plasma leptin and adiponectin with insulin sensitivity and beta-cell function in children - the Taipei Children Heart Study. Int J Clin Pract 60: 1582-1587, 2006.","DOI":"10.1111\/j.1742-1241.2006.00909.x"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Hara K, Horikoshi M, Yamauchi T, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29: 1357-1362, 2006.","DOI":"10.2337\/dc05-1801"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism 53: 1-3, 2004.","DOI":"10.1016\/j.metabol.2003.07.002"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Lithell H, Boberg J, Hellsing K, et al. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy. Eur J Clin Invest 11: 3-10, 1981.","DOI":"10.1111\/j.1365-2362.1981.tb01758.x"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 68: 860-866, 1993.","DOI":"10.1016\/S0025-6196(12)60694-6"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Hoppichler F, Sandholzer C, Moncayo R, Utermann G, Kraft HG. Thyroid hormone (fT4) reduces lipoprotein(a) plasma levels. Atherosclerosis 115: 65-71, 1995.","DOI":"10.1016\/0021-9150(94)05500-I"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/15\/54_54.0668\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T23:51:36Z","timestamp":1567036296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/15\/54_54.0668\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":51,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.0668","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}